
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation

Gorilla Technology Group’s AI Solution Assists London’s Metropolitan Police Secure Successful Convictions in Complex Homicide Investigation
